Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This study will determine if docetaxel will be administered before or after
doxorubicin/cyclophosphamides in an adjuvant chemotherapy regimen to be evaluated in a
subsequent phase III trial.